Quaker Chemical Résultats passés
Passé contrôle des critères 1/6
Les bénéfices de Quaker Chemical ont diminué à un taux annuel moyen de -19.9%, tandis que le secteur Chemicals a vu ses bénéfices augmenter de en baisse à 2.9% par an. Les revenus ont augmenté de en à un taux moyen de 1.5% par an. Le rendement des capitaux propres de Quaker Chemical est 7.1% et ses marges nettes sont de 4.9%.
Informations clés
-19.88%
Taux de croissance des bénéfices
-19.71%
Taux de croissance du BPA
| Chemicals Croissance de l'industrie | 12.93% |
| Taux de croissance des recettes | 1.51% |
| Rendement des fonds propres | 7.08% |
| Marge nette | 4.93% |
| Dernière mise à jour des bénéfices | 30 Jun 2026 |
Mises à jour récentes des performances passées
Recent updates
Mise à jour du récit • Sep 03
KWR: Volume Upside And Acquisitions Will Support Future P/E Re Rating
Analysts have lifted their fair value estimate for Quaker Chemical to $200 from $180, citing higher assumed revenue growth, a richer future P/E multiple, slightly lower discount rates, and recent Street research that highlights above market volume trends, resilient pricing, and ongoing acquisition driven expansion. Analyst Commentary on Quaker Chemical Recent Street research on Quaker Chemical points to a constructive backdrop, with several bullish analysts raising price targets and highlighting execution on both growth and profitability.
Mise à jour du récit • Aug 16
KWR: Pricing Power And Bolt-On Deals Will Support Future Upside
Analysts have lifted their fair value estimate for Quaker Chemical to $189.71 from $179.86, citing higher Street price targets supported by recent Q2 outperformance, expectations for mid single digit EBITDA growth into 2026, and views that the company can continue to use pricing, volume trends, and bolt on deals to support earnings. Analyst Commentary Recent research on Quaker Chemical focuses on Q2 execution, pricing power, and the outlook for EBITDA growth into 2026 and beyond.Article d’analyse • Aug 07
Quaker Chemical's (NYSE:KWR) Earnings May Just Be The Starting Point
When companies post strong earnings, the stock generally performs well, just like Quaker Chemical Corporation's...Seeking Alpha • Aug 06
Quaker Chemical: Building Value Through Integrated Industrial Solutions
Summary Quaker Chemical is transforming into a manufacturing solutions provider, integrating technical expertise and digital support to deepen customer relationships and raise switching costs. KWR's disciplined capital allocation—focused on R&D, strategic acquisitions, and operational improvements—has driven consistent market share gains and four consecutive quarters of adjusted EBITDA growth. Despite premium valuation multiples (~22.10x P/E, ~11.45x EV/EBITDA), KWR's business quality and durable earnings growth remain underappreciated by the market. I maintain a Buy rating, as sustained execution and improved business quality should drive long-term shareholder returns, with valuation multiple expansion as a secondary catalyst. Read the full article on Seeking AlphaMise à jour du récit • Aug 02
KWR: Pricing Power And Cost Discipline Will Drive Future Earnings Support
Analysts have lifted the fair value estimate for Quaker Chemical by about $10 to $179.86, pointing to higher Street price targets in the $172 to $177 range. They cite expectations for slight Q2 outperformance, solid competitive positioning in industrial process fluids, and future earnings support from pricing power and cost improvements.Mise à jour du récit • Jun 18
KWR: Pricing Power And Cost Execution Will Support Future Upside
Analysts have nudged their fair value estimate for Quaker Chemical slightly higher to about $170 per share. This reflects updated expectations around margins, earnings power and valuation that echo recent research highlighting the company’s competitive position in industrial process fluids.Mise à jour du récit • Jun 04
KWR: Buybacks And Execution Will Support Future Upside Potential
Narrative Update: Quaker Chemical (Quaker Houghton) The updated analyst price target for Quaker Chemical moves from $183 to $169.50, as analysts factor in recent target changes, fresh coverage with a bullish stance, and revised expectations for revenue growth, profitability, and future P/E multiples. Analyst Commentary Recent Street research on Quaker Chemical points to a mixed but constructive view, with some analysts lifting price targets or initiating with a positive stance, while another has taken a more cautious approach by trimming expectations.Mise à jour du récit • May 20
KWR: Margin Strength And Share Gains Will Support Future P/E Re Rating
Analysts have raised their average price target on Quaker Houghton by $6, citing higher assumed profit margins and a lower future P/E multiple as the main factors behind the updated outlook. Analyst Commentary Recent Street research has highlighted a mix of price target revisions and rating changes on Quaker Houghton, with several bullish analysts pointing to supportive factors for the stock.Mise à jour du récit • May 01
KWR: Share Gains And M&A Execution Will Support Future P/E Premium
Analysts have modestly reduced the fair value estimate for Quaker Chemical to $180 from $184. This reflects updated views on slightly higher long term revenue growth, a somewhat stronger profit margin profile, a lower assumed future P/E multiple, and a marginally lower discount rate following a mix of recent target cuts and upgrades on the stock.Mise à jour du récit • Apr 17
KWR: Market Share Gains And M&A Activity Will Support Future P/E Premium
Analysts have trimmed their average price target for Quaker Chemical to about $184 from roughly $203 as they factor in softer revenue growth assumptions, a lower future P/E, and updated views from recent research that cites more moderate sales and EBITDA expectations despite ongoing share gains in subdued end markets. Analyst Commentary Recent research on Quaker Houghton has been mixed, but several bullish analysts still see room for upside based on execution, valuation, and the company’s ability to grow share even in softer end markets.Mise à jour du récit • Apr 01
KWR: M&A Execution And Share Gains Will Support Future Upside
Narrative Update: Quaker Chemical Analyst Price Target Shift Analysts now center their price target for Quaker Chemical around $183, reflecting a blend of Seaport's downgrade, Deutsche Bank's lift to $170, and RBC Capital's reset to $184 after Q4 results and softer 2026 guidance, while still acknowledging ongoing share gains in flat to slightly weaker end markets. Analyst Commentary Recent research on Quaker Chemical highlights a split view on how the story stacks up after Q4 results and updated guidance, with price targets clustering in the mid to high $100s.Mise à jour du récit • Mar 17
KWR: Market Share Gains And M&A Focus Will Support Premium P/E Multiple
Quaker Chemical's updated analyst price target has moved from $190 to $203, with analysts pointing to revised assumptions on revenue growth, profit margins, and a higher future P/E multiple, informed by recent target changes at firms covering Quaker Houghton. Analyst Commentary Recent research on Quaker Chemical, which operates as Quaker Houghton, reflects a mix of higher and lower price targets and at least one ratings downgrade, giving you a range of views on how the company is executing and how the stock is valued today.Mise à jour du récit • Mar 03
KWR: Higher Earnings Multiple And M&A Activity Will Support Future Upside
Analysts have lifted their blended price target for Quaker Houghton to about $183, up from roughly $172, as they weigh softer guidance and margin assumptions against continued share gains and updated P/E expectations reflected in recent research moves. Analyst Commentary Recent research on Quaker Houghton reflects a mix of optimism and caution, with price targets being fine tuned around updated growth, margin and P/E expectations following the latest earnings and guidance.Mise à jour du récit • Feb 17
KWR: Updated Assumptions And Mixed Ratings Will Shape Balanced Future Expectations
Analysts have raised their price target on Quaker Chemical to $172.25 from $166. This change reflects updated views on fair value, a slightly lower discount rate, modest adjustments to long-term revenue and margin assumptions, and a somewhat higher assumed future P/E multiple.Mise à jour du récit • Feb 03
KWR: Higher Margin Assumptions Will Reframe Earnings Risk Ahead Of Results
Analysts have raised their fair value estimate for Quaker Chemical to $190 from $165, reflecting updated assumptions around discount rates, revenue growth, profit margins and future P/E levels in recent research. Analyst Commentary Recent Street research on Quaker Chemical points to a mixed but increasingly engaged analyst view, with some firms revisiting their assumptions around earnings and valuation ahead of upcoming results.Mise à jour du récit • Jan 20
KWR: Completed Buybacks And Steady Assumptions Will Shape Balanced Future Prospects
Analysts have reaffirmed their view on Quaker Chemical, keeping the fair value estimate steady at $166.00 as small tweaks to discount rate, revenue growth, profit margin and future P/E assumptions did not materially shift their overall price target framework. What's in the News From July 1, 2025 to September 30, 2025, Quaker Chemical repurchased 29,791 shares for $3.81 million, representing 0.17% of its shares.Article d’analyse • Jan 11
These 4 Measures Indicate That Quaker Chemical (NYSE:KWR) Is Using Debt Reasonably Well
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Mise à jour du récit • Jan 06
KWR: Share Repurchases And Stable Assumptions Will Support Future Upside Potential
Analysts kept their price target for Quaker Chemical steady at $166, reflecting only small model tweaks to the discount rate, revenue growth, profit margin, and future P/E assumptions rather than a change in their overall view of the shares. What's in the News From July 1, 2025 to September 30, 2025, Quaker Chemical repurchased 29,791 shares for $3.81 million, representing 0.17% of its shares.Mise à jour du récit • Dec 20
KWR: Ongoing Share Repurchases Will Likely Support Strong Future Share Performance
Narrative Update Analysts have raised their price target on Quaker Chemical by $0.00 to account for slightly lower discount rate assumptions and modest adjustments to long-term growth and profitability forecasts. What's in the News Completed share repurchase of 638,901 shares, about 3.59% of outstanding shares, for a total of $85.75 million under the buyback program announced on February 28, 2024 (company filing) Between July 1, 2025 and September 30, 2025, repurchased 29,791 shares, representing 0.17% of shares, for $3.81 million as the final tranche of the current authorization (company filing) Ongoing capital return via buybacks signals management confidence in long term cash generation and balance sheet strength (company filing) Valuation Changes Fair Value: unchanged at $166.00 per share, reflecting no net impact from the updated assumptions.Article d’analyse • Dec 19
There's Been No Shortage Of Growth Recently For Quaker Chemical's (NYSE:KWR) Returns On Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Mise à jour du récit • Dec 06
KWR: Ongoing Share Repurchases Will Likely Support Strong Future Share Performance
Narrative Update on Quaker Chemical Analysts have maintained their price target for Quaker Chemical at approximately 166 dollars, as modest adjustments to the discount rate and long term growth assumptions were not deemed sufficient to warrant a change in fair value. What's in the News The company completed its share repurchase program announced on February 28, 2024, buying back a total of 638,901 shares, or about 3.59% of shares outstanding, for approximately 85.75 million dollars (company filing).Mise à jour du récit • Nov 22
KWR: Share Repurchases Are Expected To Drive Positive Market Reactions
Narrative Update on Quaker Chemical Analysts have raised their price target for Quaker Chemical from $162 to $166, reflecting a modest increase based on updated assessments of company valuation metrics and market outlook. What's in the News Between July 1, 2025 and September 30, 2025, Quaker Chemical repurchased 29,791 shares for $3.81 million, representing 0.17 percent of its outstanding shares (Key Developments).Mise à jour du récit • Nov 03
KWR: Expanding Share Buybacks Will Drive Stronger Profit Margins Ahead
Analysts have raised their price target for Quaker Chemical from $155.40 to $162.00. They cite improved profit margin forecasts and higher projected revenue growth as key factors in the revised valuation.Article d’analyse • Oct 02
Quaker Chemical's (NYSE:KWR) Upcoming Dividend Will Be Larger Than Last Year's
Quaker Chemical Corporation ( NYSE:KWR ) will increase its dividend from last year's comparable payment on the 31st of...Article d’analyse • Sep 24
Is There An Opportunity With Quaker Chemical Corporation's (NYSE:KWR) 48% Undervaluation?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Quaker Chemical fair value estimate is US$258 Quaker...Article d’analyse • Aug 30
Quaker Chemical Corporation's (NYSE:KWR) 26% Price Boost Is Out Of Tune With Revenues
Despite an already strong run, Quaker Chemical Corporation ( NYSE:KWR ) shares have been powering on, with a gain of...Mise à jour du récit • Aug 28
Sustainable Chemistries And Asia Expansion Will Empower Manufacturing Automation
The upward revision in Quaker Chemical’s consensus price target reflects a minor increase in forecasted future P/E ratio, while valuation inputs like the discount rate remain stable, resulting in a fair value target rising to $155.40. What's in the News Reported an $88.8 million goodwill impairment charge related to the EMEA segment, resulting in a quarterly net loss.Article d’analyse • May 28
Is Now An Opportune Moment To Examine Quaker Chemical Corporation (NYSE:KWR)?
Quaker Chemical Corporation ( NYSE:KWR ), might not be a large cap stock, but it saw a decent share price growth of 15...Article d’analyse • Apr 25
Quaker Chemical Corporation (NYSE:KWR) Shares Could Be 49% Below Their Intrinsic Value Estimate
Key Insights Quaker Chemical's estimated fair value is US$206 based on 2 Stage Free Cash Flow to Equity Quaker...Article d’analyse • Apr 08
Risks Still Elevated At These Prices As Quaker Chemical Corporation (NYSE:KWR) Shares Dive 27%
Quaker Chemical Corporation ( NYSE:KWR ) shareholders that were waiting for something to happen have been dealt a blow...Seeking Alpha • Mar 26
Quaker Chemical: Starting To Look More Attractive
Summary Quaker Chemical Corporation's valuation has become more compelling, but I'm cautious due to economic concerns and recent CEO turnover. Despite a 6% sales drop in early 2024, earnings held up, and net debt decreased to $519 million. The $153 million acquisition of Dipsol Chemicals is expected to slightly boost earnings and maintain a manageable debt level. While the KWR earnings multiple has improved, economic uncertainties and tariff impacts make me hesitant to buy now. Read the full article on Seeking AlphaVentilation des recettes et des dépenses
Ventilation des recettes et des dépenses
Comment Quaker Chemical gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Jun 26 | 1,975 | 97 | 402 | 61 |
| 31 Mar 26 | 1,926 | 4 | 388 | 61 |
| 31 Dec 25 | 1,889 | -2 | 368 | 61 |
| 30 Sep 25 | 1,864 | -9 | 378 | 57 |
| 30 Jun 25 | 1,833 | -7 | 370 | 57 |
| 31 Mar 25 | 1,813 | 94 | 361 | 57 |
| 31 Dec 24 | 1,840 | 116 | 369 | 57 |
| 30 Sep 24 | 1,863 | 122 | 377 | 50 |
| 30 Jun 24 | 1,891 | 123 | 381 | 50 |
| 31 Mar 24 | 1,923 | 118 | 382 | 50 |
| 31 Dec 23 | 1,953 | 112 | 377 | 50 |
| 30 Sep 23 | 1,971 | 16 | 369 | 46 |
| 30 Jun 23 | 1,973 | 9 | 368 | 46 |
| 31 Mar 23 | 1,970 | -6 | 359 | 46 |
| 31 Dec 22 | 1,944 | -16 | 359 | 46 |
| 30 Sep 22 | 1,906 | 78 | 338 | 45 |
| 30 Jun 22 | 1,863 | 83 | 321 | 45 |
| 31 Mar 22 | 1,806 | 102 | 320 | 45 |
| 31 Dec 21 | 1,761 | 121 | 313 | 45 |
| 30 Sep 21 | 1,700 | 151 | 318 | 40 |
| 30 Jun 21 | 1,618 | 147 | 310 | 40 |
| 31 Mar 21 | 1,469 | 106 | 311 | 40 |
| 31 Dec 20 | 1,418 | 40 | 306 | 40 |
| 30 Sep 20 | 1,423 | 6 | 348 | 32 |
| 30 Jun 20 | 1,381 | -34 | 333 | 32 |
| 31 Mar 20 | 1,301 | -11 | 275 | 32 |
| 31 Dec 19 | 1,134 | 32 | 227 | 32 |
| 30 Sep 19 | 954 | 24 | 204 | 25 |
| 30 Jun 19 | 851 | 57 | 176 | 25 |
| 31 Mar 19 | 867 | 60 | 180 | 25 |
| 31 Dec 18 | 868 | 59 | 178 | 25 |
| 30 Sep 18 | 867 | 42 | 210 | 0 |
| 30 Jun 18 | 858 | 33 | 208 | 0 |
| 31 Mar 18 | 837 | 26 | 205 | 0 |
| 31 Dec 17 | 820 | 20 | 171 | 24 |
| 30 Sep 17 | 800 | 47 | 202 | 0 |
| 30 Jun 17 | 778 | 52 | 198 | 0 |
| 31 Mar 17 | 763 | 55 | 196 | 0 |
| 31 Dec 16 | 747 | 61 | 196 | 0 |
| 30 Sep 16 | 739 | 55 | 195 | 0 |
| 30 Jun 16 | 737 | 53 | 197 | 0 |
| 31 Mar 16 | 734 | 53 | 196 | 0 |
| 31 Dec 15 | 738 | 51 | 196 | 0 |
| 30 Sep 15 | 748 | 52 | 198 | 0 |
Des revenus de qualité: KWR a un important ponctuel perte de $36.4M impactant ses 12 derniers mois de résultats financiers à 30th June, 2026.
Augmentation de la marge bénéficiaire: KWR est devenu rentable dans le passé.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: Les bénéfices de KWR ont diminué de 19.9% par an au cours des 5 dernières années.
Accélération de la croissance: KWR est devenu rentable au cours de l'année dernière, ce qui rend le taux de croissance des bénéfices difficile à comparer à sa moyenne sur 5 ans.
Bénéfices par rapport au secteur d'activité: KWR est devenue rentable au cours de l'année dernière, ce qui rend difficile la comparaison de sa croissance des bénéfices de l'année écoulée avec celle du secteur Chemicals ( 2.4% ).
Rendement des fonds propres
ROE élevé: Le retour sur capitaux propres de KWR ( 7.1% ) est considéré comme faible.
Rendement des actifs
Rendement des capitaux employés
Découvrir des entreprises performantes dans le passé
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/09/14 09:30 |
| Cours de l'action en fin de journée | 2026/09/11 00:00 |
| Les revenus | 2026/06/30 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.
Découvrez l' qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Quaker Chemical Corporation est couverte par 14 analystes. 7 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Michael Gaugler | Brean Capital Historical (Janney Montgomery) |
| Liam Burke | B. Riley Securities, Inc. |
| Jonathan Tanwanteng | CJS Securities, Inc. |